# Discovery Life Sciences, LLC

Canonical: https://abierto.us/vendors/discovery-life-sciences-llc-gdjdufgmsc14

- UEI: GDJDUFGMSC14
- CAGE: 665G5
- Location: Huntsville, AL
- Awards in window: 4 (4 transactions), $119,570 obligated, February 16, 2024 to September 16, 2024

## Awarding agencies

- Food and Drug Administration: 2 awards, $90,880
- National Institutes of Health: 1 awards, $28,690
- Agricultural Research Service: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $119,570

## Competition

- Competed Under SAP: 3 awards
- Not Competed Under SAP: 1 awards

## Solicitations won

- Primary Cryopreserved Human Hepatocytes and Media (75F40124Q-123069). https://abierto.us/opportunities/75f40124q123069

## Largest awards

- 75F40124P00280 (purchase order): $91,630, FDA Office of Acq Grant SVCS. Primary Cryopreserved Human Hepatocytes and Media. https://www.usaspending.gov/award/CONT_AWD_75F40124P00280_7524_-NONE-_-NONE-/
- 75N92024P00333 (purchase order): $28,690, National Institutes of Health Nhlbi. Services, Storage, and Shipping to Obtain Hla-B27+ Healthy Control Biospecimens National Institute of Arthritis and Musculoskeletal and Skin Diseases (Niams). These Samples Will Serve as Controls for the Agency Cohort of Patients with Hla-B27+ Axial. https://www.usaspending.gov/award/CONT_AWD_75N92024P00333_7529_-NONE-_-NONE-/
- 12805B23P0431 (purchase order): $0, USDA ARS PA Aao Acq/Per Prop. Long Read Sequencing. https://www.usaspending.gov/award/CONT_AWD_12805B23P0431_12H2_-NONE-_-NONE-/
- 75F40122P00123 (purchase order): -$750, FDA Office of Acq Grant SVCS. The Purpose of This Modification Is to De-Obligate Excess Funds and Close Out the Contract.. https://www.usaspending.gov/award/CONT_AWD_75F40122P00123_7524_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/discovery-life-sciences-llc-gdjdufgmsc14.